Otherwise, SLAMF3 overexpression in HCC cells specifically inhibits the expression and activity of multidrug resistance protein-1 (MRP-1), which is overexpressed in HCC cells and involved in resistance to drugs, such as sorafenib [14,19]. This evidence concerns the gene LY9 and hepatocellular carcinoma.